GST Council cuts tax on COVID-19 medicines, equipment


PTI, Jun 12, 2021, 4:02 PM IST

New Delhi: The GST Council on Saturday slashed the tax rate on COVID-19 medicines such as Remdesivir and equipment like oxygen concentrators and medical grade oxygen.

While GST on Tocilizumab and Amphotericin B is slashed to nil from 5 per cent, the rate on Remdesivir and anti-coagulants like Heparin is lowered from 12 per cent to 5 per cent.

Tax on medical grade oxygen, oxygen concentrators, ventilators, BiPAP machines and high flow nasal cannula (HFNC) devices has been cut to 5 per cent from 12 per cent, Finance Minister Nirmala Sitharaman said.

Also, tax on Covid testing kits has been brought down to 5 per cent from 12 per cent.

Pulse oximeters, hand sanitisers, temperature check equipment and ambulances too will attract lower 5 per cent tax, she said.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

NIA arrests key accused in 2023 attack on Indian High Commission in London

IT sleuths threatening raided leaders to claim money belongs to me, Cong: DK Shivakumar

MCC violation: Karnataka HC grants interim relief to Shivakumar

Second phase of LS polls: Polling on Friday for 88 seats in 13 states

Parliament security breach: Court grants Delhi Police additional time to complete probe

Orange alert: Karnataka State Disaster Management cell issues animated advisory

PM Modi to begin 2-day whirlwind campaign in Karnataka from Apr 28

MUST WATCH

Skin Rash, Causes, Signs and Symptoms

11 bullets found in python’s body!

K. Jayaprakash Hegde Sharing His Memories

Grafting Jack Anil

Heat Illness


Latest Additions

NIA arrests key accused in 2023 attack on Indian High Commission in London

Three persons run over by train in Bengaluru

Indian nationals aboard ‘MSC Aries’ in good health, return delayed due to technicalities: MEA

Husband has no control over wife’s ‘stridhan’: SC

IT sleuths threatening raided leaders to claim money belongs to me, Cong: DK Shivakumar

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.